Results 241 to 250 of about 3,660,140 (254)

Safety of Virus-Resistant Transgenic Plants Two Decades After Their Introduction: Lessons from Realistic Field Risk Assessment Studies*

Annual Review of Phytopathology, 2007
Marc Fuchs, Dennis Gonsalves
exaly  

Human cancer virus vaccines

Ca-A Cancer Journal for Clinicians, 1974
Maurice R Hilleman
exaly  

Immunologic and virus studies with human sarcomas

Ca-A Cancer Journal for Clinicians, 1970
D L Morton
exaly  

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

Annals of Oncology, 2011
Mu-Shui Dai, Yu-Chieh Su, Andrew M Evens
exaly  

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

Open Forum Infectious Diseases, 2015
Rebecca Sheets, Georgia D. Tomaras, Mary Allen   +2 more
exaly  

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity

Vaccine, 2004
Qigai He, Bin Wu, Zili Li
exaly  

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects

Expert Review of Vaccines, 2011
David W C Beasley
exaly  

The human cancer virus task force: A new approach to virus-cancer research

Ca-A Cancer Journal for Clinicians, 1963
exaly  

Safety of Adeno-Associated Virus as Cochlear Gene Transfer Vector: Analysis of Distant Spread Beyond Injected Cochleae

Molecular Therapy, 2000
Anil K Lalwani, Anand N Mhatre
exaly  

Safety profile of live varicella virus vaccine (Oka/Merck): Five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)

Vaccine, 2010
Mark Quinlivan, Judy Breuer
exaly